









Markets
/
Stocks
/
nasdaq-crmd
/

CorMedix Inc

CRMD

View Detailed Chart

16.560USD

+2.950+21.68%

Close 06/23, 16:00（ET）Quotes delayed by 15 min

1.12BMarket Cap

LossP/E TTM



CorMedix Inc

16.560

+2.950+21.68%

Company

Intraday

30m

Today

+21.68%

5 Days

+15.48%

1 Month

+33.98%

6 Months

+96.67%

Year to Date

+104.44%

1 Year

+277.22%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts

BUY

Current Rating

18.833

Target Price

38.38%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

167

Total

Median

Average

Company name

Ratings

Analysts

CorMedix Inc

CRMD

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(4)

Buy(6)

Indicators

Sell(2)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.271

Neutral

RSI(14)

57.686

Neutral

STOCH(KDJ)(9,3,3)

25.835

Sell

ATR(14)

0.701

High Vlolatility

CCI(14)

-17.339

Neutral

Williams %R

54.226

Neutral

TRIX(12,20)

1.071

Sell

StochRSI(14)

2.091

Oversold

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

14.006

Buy

MA10

14.270

Buy

MA20

13.376

Buy

MA50

11.204

Buy

MA100

10.407

Buy

MA200

9.980

Buy

News

More news coming soon, stay tuned...

Company

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.

Ticker SymbolCRMD

CompanyCorMedix Inc

CEOMr. Joseph Todisco

Websitehttps://cormedix.com/